Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression

Shumei Song, Scott M. Lippman, Yiyu Zou, Xiaofeng Ye, Jaffer A. Ajani, Xiao Chun Xu

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Benzo[a]pyrene diol epoxide (BPDE, a carcinogen present in tobacco smoke and environmental pollution) has been shown to suppress retinoic acid receptor-beta2 (RAR-β2) and induce cyclooxygenase-2 (COX-2) expression. Restoration of RAR-β2 inhibited growth and colony formation of esophageal cancer cells, which was correlated with COX-2 suppression. In this study, we investigated the molecular mechanisms for RAR-β2-mediated suppression of COX-2 expression using BPDE as a tool. We found that BPDE-induced COX-2 expression was through inhibition of RAR-β2 and consequently, induction of epidermal growth factor receptor (EGFR), extracellular signal-regulated protein kinases 1/2 (Erk1/2) phosphorylation, and c-Jun expression. Esophageal cancer cells that do not express RAR-β2 did not respond to BPDE for induction of COX-2. BPDE was also unable to induce COX-2 expression after RAR-β2 expression was manipulated in these esophageal cancer cells. Furthermore, BPDE induced time-dependent methylation of RAR-β2 gene promoter in esophageal cancer cells. Transfection of RAR-β2 expression vector into esophageal cancer cells suppressed expression of EGFR, Erk1/2 phosphorylation, c-Jun, and COX-2. In addition, co-treatment of RAR-β2-positive cells with BPDE and the MEK1/2 inhibitor U0126 caused little change in c-Jun and COX-2 expression. This study demonstrated that BPDE-suppressed expression of RAR-β2 results in COX-2 induction and restoration of RAR-β2 expression reduces COX-2 protein in esophageal cancer cells, thereby further supporting our previous finding that RAR-β2 plays an important role in suppressing esophageal carcinogenesis.

Original languageEnglish (US)
Pages (from-to)8268-8276
Number of pages9
JournalOncogene
Volume24
Issue number56
DOIs
StatePublished - Dec 15 2005

Fingerprint

Retinoic Acid Receptors
Benzo(a)pyrene
Epoxy Compounds
Cyclooxygenase 2
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
Esophageal Neoplasms
Mitogen-Activated Protein Kinase 3
Epidermal Growth Factor Receptor
Protein Kinases
Phosphorylation
Tobacco Smoke Pollution
Carcinogens
Methylation
Transfection
Carcinogenesis

Keywords

  • AP-1
  • BPDE
  • COX-2
  • Erk1/2
  • Esophageal cancer
  • RAR-β

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression. / Song, Shumei; Lippman, Scott M.; Zou, Yiyu; Ye, Xiaofeng; Ajani, Jaffer A.; Xu, Xiao Chun.

In: Oncogene, Vol. 24, No. 56, 15.12.2005, p. 8268-8276.

Research output: Contribution to journalArticle

Song, Shumei ; Lippman, Scott M. ; Zou, Yiyu ; Ye, Xiaofeng ; Ajani, Jaffer A. ; Xu, Xiao Chun. / Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression. In: Oncogene. 2005 ; Vol. 24, No. 56. pp. 8268-8276.
@article{3386804c894443bba60fdf86dfa4dba2,
title = "Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression",
abstract = "Benzo[a]pyrene diol epoxide (BPDE, a carcinogen present in tobacco smoke and environmental pollution) has been shown to suppress retinoic acid receptor-beta2 (RAR-β2) and induce cyclooxygenase-2 (COX-2) expression. Restoration of RAR-β2 inhibited growth and colony formation of esophageal cancer cells, which was correlated with COX-2 suppression. In this study, we investigated the molecular mechanisms for RAR-β2-mediated suppression of COX-2 expression using BPDE as a tool. We found that BPDE-induced COX-2 expression was through inhibition of RAR-β2 and consequently, induction of epidermal growth factor receptor (EGFR), extracellular signal-regulated protein kinases 1/2 (Erk1/2) phosphorylation, and c-Jun expression. Esophageal cancer cells that do not express RAR-β2 did not respond to BPDE for induction of COX-2. BPDE was also unable to induce COX-2 expression after RAR-β2 expression was manipulated in these esophageal cancer cells. Furthermore, BPDE induced time-dependent methylation of RAR-β2 gene promoter in esophageal cancer cells. Transfection of RAR-β2 expression vector into esophageal cancer cells suppressed expression of EGFR, Erk1/2 phosphorylation, c-Jun, and COX-2. In addition, co-treatment of RAR-β2-positive cells with BPDE and the MEK1/2 inhibitor U0126 caused little change in c-Jun and COX-2 expression. This study demonstrated that BPDE-suppressed expression of RAR-β2 results in COX-2 induction and restoration of RAR-β2 expression reduces COX-2 protein in esophageal cancer cells, thereby further supporting our previous finding that RAR-β2 plays an important role in suppressing esophageal carcinogenesis.",
keywords = "AP-1, BPDE, COX-2, Erk1/2, Esophageal cancer, RAR-β",
author = "Shumei Song and Lippman, {Scott M.} and Yiyu Zou and Xiaofeng Ye and Ajani, {Jaffer A.} and Xu, {Xiao Chun}",
year = "2005",
month = "12",
day = "15",
doi = "10.1038/sj.onc.1208992",
language = "English (US)",
volume = "24",
pages = "8268--8276",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "56",

}

TY - JOUR

T1 - Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression

AU - Song, Shumei

AU - Lippman, Scott M.

AU - Zou, Yiyu

AU - Ye, Xiaofeng

AU - Ajani, Jaffer A.

AU - Xu, Xiao Chun

PY - 2005/12/15

Y1 - 2005/12/15

N2 - Benzo[a]pyrene diol epoxide (BPDE, a carcinogen present in tobacco smoke and environmental pollution) has been shown to suppress retinoic acid receptor-beta2 (RAR-β2) and induce cyclooxygenase-2 (COX-2) expression. Restoration of RAR-β2 inhibited growth and colony formation of esophageal cancer cells, which was correlated with COX-2 suppression. In this study, we investigated the molecular mechanisms for RAR-β2-mediated suppression of COX-2 expression using BPDE as a tool. We found that BPDE-induced COX-2 expression was through inhibition of RAR-β2 and consequently, induction of epidermal growth factor receptor (EGFR), extracellular signal-regulated protein kinases 1/2 (Erk1/2) phosphorylation, and c-Jun expression. Esophageal cancer cells that do not express RAR-β2 did not respond to BPDE for induction of COX-2. BPDE was also unable to induce COX-2 expression after RAR-β2 expression was manipulated in these esophageal cancer cells. Furthermore, BPDE induced time-dependent methylation of RAR-β2 gene promoter in esophageal cancer cells. Transfection of RAR-β2 expression vector into esophageal cancer cells suppressed expression of EGFR, Erk1/2 phosphorylation, c-Jun, and COX-2. In addition, co-treatment of RAR-β2-positive cells with BPDE and the MEK1/2 inhibitor U0126 caused little change in c-Jun and COX-2 expression. This study demonstrated that BPDE-suppressed expression of RAR-β2 results in COX-2 induction and restoration of RAR-β2 expression reduces COX-2 protein in esophageal cancer cells, thereby further supporting our previous finding that RAR-β2 plays an important role in suppressing esophageal carcinogenesis.

AB - Benzo[a]pyrene diol epoxide (BPDE, a carcinogen present in tobacco smoke and environmental pollution) has been shown to suppress retinoic acid receptor-beta2 (RAR-β2) and induce cyclooxygenase-2 (COX-2) expression. Restoration of RAR-β2 inhibited growth and colony formation of esophageal cancer cells, which was correlated with COX-2 suppression. In this study, we investigated the molecular mechanisms for RAR-β2-mediated suppression of COX-2 expression using BPDE as a tool. We found that BPDE-induced COX-2 expression was through inhibition of RAR-β2 and consequently, induction of epidermal growth factor receptor (EGFR), extracellular signal-regulated protein kinases 1/2 (Erk1/2) phosphorylation, and c-Jun expression. Esophageal cancer cells that do not express RAR-β2 did not respond to BPDE for induction of COX-2. BPDE was also unable to induce COX-2 expression after RAR-β2 expression was manipulated in these esophageal cancer cells. Furthermore, BPDE induced time-dependent methylation of RAR-β2 gene promoter in esophageal cancer cells. Transfection of RAR-β2 expression vector into esophageal cancer cells suppressed expression of EGFR, Erk1/2 phosphorylation, c-Jun, and COX-2. In addition, co-treatment of RAR-β2-positive cells with BPDE and the MEK1/2 inhibitor U0126 caused little change in c-Jun and COX-2 expression. This study demonstrated that BPDE-suppressed expression of RAR-β2 results in COX-2 induction and restoration of RAR-β2 expression reduces COX-2 protein in esophageal cancer cells, thereby further supporting our previous finding that RAR-β2 plays an important role in suppressing esophageal carcinogenesis.

KW - AP-1

KW - BPDE

KW - COX-2

KW - Erk1/2

KW - Esophageal cancer

KW - RAR-β

UR - http://www.scopus.com/inward/record.url?scp=32844463384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32844463384&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208992

DO - 10.1038/sj.onc.1208992

M3 - Article

C2 - 16170369

AN - SCOPUS:32844463384

VL - 24

SP - 8268

EP - 8276

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 56

ER -